Muutoksia Suominen Oyj:n johdolle ja avainhenkilöille suunnattuihin osakepohjaisiin kannustinjärjestelmiin sekä toimitusjohtajan osakepohjaiseen aloituspalkkioon ja vuosittaiseen osakepalkkioon

Suominen adjusted share-based incentive plans following its July 2026 rights issue, which increased shares outstanding by 77.1 million to 135.4 million. To preserve the euro value of awards after dilution, the company applied a 1.621 share-count multiplier (equivalent adjustment factor 0.62), raising maximum awards across long-term incentive plans and the retention plan from 200,000 to 324,000 shares. CEO Charles Héaulmé's 2026 signing award rises from 200,000 to 324,000 shares, while maximum annual award amounts for 2026 and 2027 rise from 500,000 to 810,000 shares; the underlying economic value and performance conditions are unchanged.

Analysis

This is economically neutral anti-dilution housekeeping rather than incremental compensation value: the adjustment preserves pre-rights-issue euro value. The relevant near-term signal is instead governance optics—management’s nominal share awards rise sharply immediately after a deeply dilutive recapitalization, which can weigh on a small-cap valuation multiple if investors perceive the board as insulating insiders more fully than outside holders.

The CEO’s September share delivery is a modest technical overhang only if treasury shares are insufficient or recipients sell to fund taxes; the stated use of treasury stock means no new issuance is implied at payment. More importantly, the 2026 CEO award retains a meaningful EBITDA hurdle, making the 2027 delivery a read-through on whether operating recovery can reach €20m/€25m/€30m. The hurdle structure creates alignment at target and above, but a portion of future awards is effectively retention-based, reducing pure pay-for-performance sensitivity.

Over the next 1-3 months, this should not alter earnings estimates or capital structure, so a standalone trade is unwarranted. Over 6-18 months, the market should focus on whether the rights issue converts into sustainable EBITDA and free-cash-flow improvement; absent that, a larger equity base and recurring equity compensation can amplify per-share return dilution even if absolute profitability improves. Falsification of the governance concern would be clear progress toward the €25m comparable-EBITDA target alongside disciplined share-count management and no further equity-funded balance-sheet actions.

Key Decisions for Investors

• No directional position in SUY1V on this announcement alone; expected fundamental impact is negligible and the adjustment is mechanically value-neutral.
• Set a watch alert for Q3/Q4 2026 comparable EBITDA trajectory versus the €20m minimum and €25m target embedded in the CEO award. Upgrade only if run-rate evidence supports the target without renewed working-capital stress or revised equity financing.
• For existing SUY1V holders, monitor September 30 treasury-share transfer and subsequent insider ownership filings; unexpected market sales or any incremental issuance would reinforce per-share dilution risk and justify reducing exposure.
• Treat any valuation rerating as contingent on post-recapitalization FCF conversion, not headline EBITDA alone: inventories, receivables, capex, and net debt need to improve concurrently over the next two reporting periods.